FOMAT

Blogs and updates

Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed

Blood Test
Simple Blood Test a Possible Tool for Early Cancer Diagnosis
High levels of calcium in blood, a condition known as hypercalcemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter.  Hypercalcemia is the...
Read More
Stomach Photo Being Injected with Vaccine for Ebola Trial Patient
1st Volunteer Gets Experimental Ebola Vaccine
British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety. Ruth Atkins, 48, got the injection on Wednesday in Oxford, the first of...
Read More
Male pattern baldness
Certain Form Of Baldness Linked To Prostate Cancer
A new, large cohort analysis from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, indicates that men who had moderate baldness affecting both the front and the crown of their head at age 45 were at a 40%...
Read More
PAK Inhibitor Research
Schizophrenia is Actually 8 Genetic Disorders
New research shows that schizophrenia isn’t a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be the first step toward improved diagnosis and treatment for the debilitating psychiatric illness....
Read More
ChAd3 vaccine
Two Anti-Ebola Vaccines in Historic Race
One of the most rapidly fast-tracked vaccines in history—an anti-Ebola “ChAd3” vaccine—just entered clinical trial in humans. It may wrap in November. It protected macaques for five weeks, leaping to 10 months when followed by a booster two months later. It...
Read More
Ebola virus therapeutics
The Search for Ebola Response Targets
The effort to develop therapeutics and a vaccine against the deadly Ebola virus disease (EVD) requires a complex understanding of the microorganism and its relationship with the host, especially the immune response. Adding to the challenge, EVD can be caused by...
Read More
Nicotine vaccine
J&J accelerate Ebola Vaccine Development
Johnson & Johnson announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partners in global health to deliver immediate relief aid to address the current Ebola outbreak. The accelerated vaccine...
Read More
Biosimilar drugs
FDA: Little Evidence to Support Testosterone Drugs
The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious testosterone therapy risks. The agency posted its...
Read More
Genomic sequencing
Animal to Human Transmission Responsible for 2014 Ebola Outbreak
Scientists used advanced genomic sequencing technology to identify a single point of infection from an animal reservoir to a human in the current Ebola outbreak in West Africa. This research has also revealed the dynamics of how the Ebola virus has...
Read More
Ebola outbreak response
Ebola Vaccine is in Safety Testing
This Aug. 12, 2014 file photo shows a healthcare worker walking near an Ebola isolation unit, part of the Ebola outbreak response, wearing protective gear against the virus at Kenema Government Hospital in Kenema, Sierra Leone. Federal researchers next week will...
Read More
Ebola Warning Sign Disease
3rd Doctor Dies from Ebola
During a training session participants listen as they stand over a mannequin on a stretcher during a training course to instruct non-governmental organization (NGO) workers and doctors on how to deal with the Ebola virus in Brussels on Tuesday, Aug. 26,...
Read More
Ebola treatment decisions
Liberia Gets ZMapp
Liberia women sing after praying for help with the Ebola virus, in the city of Monrovia, Liberia. Thursday, Aug. 14, 2014. Liberia faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove...
Read More